William Abraham
- Late-breaking abstract: Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthmaBy Christopher Hewson, Sheena Patel, Luigino Calzetta, Hinnah Campwala, Suzanne Havard, Emma Luscombe, Philip Clarke, Peter Peachell, Maria Matera, Mario Cazzola, Clive Page, William Abraham, Cara Williams, James Clark, Nicholas Clarke and Michael YeadonChristopher Hewson1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United KingdomSheena Patel1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United KingdomLuigino Calzetta2Unit of Respiratory Clinical Pharmacology, Dept. Internal Medicine, University of Rome “Tor Vergata”, Rome, ItalyHinnah Campwala1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United KingdomSuzanne Havard3Academic Unit of Respiratory Medicine, University of Sheffield, Sheffield, S Yorks, United KingdomEmma Luscombe1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United KingdomPhilip Clarke1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United KingdomPeter Peachell3Academic Unit of Respiratory Medicine, University of Sheffield, Sheffield, S Yorks, United KingdomMaria Matera4Unit of Pharmacology, Dept. Experimental Medicine, Second University of Naples, Naples, ItalyMario Cazzola2Unit of Respiratory Clinical Pharmacology, Dept. Internal Medicine, University of Rome “Tor Vergata”, Rome, ItalyClive Page5Sackler Institute of Pulmonary Pharmacology, King's College London, London, United KingdomWilliam Abraham6Dept. Research, Mount Sinai Medical Center, Miami Beach, FL, United StatesCara Williams7Inflammation & Immunity Research Unit, Pfizer, Cambridge, MA, United StatesJames Clark7Inflammation & Immunity Research Unit, Pfizer, Cambridge, MA, United StatesNicholas Clarke1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United KingdomMichael Yeadon1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United Kingdom
- Respiratory event hospitalizations are reduced in heart failure patients with comorbid chronic obstructive pulmonary disease using a wireless implanted pulmonary artery pressure monitoring systemBy Fernando Martinez, Robert Bourge, Raymond Benza, William Abraham, Philip Adamson, Jay Yadav, Brad Jeffries, Jordan Bauman and Gerard CrinerFernando Martinez1Internal Medicine, University of Michigan Health System, Ann Arbor, MI, United StatesRobert Bourge2Cardiology, University of Alabama at Birmingham, AL, United StatesRaymond Benza3Cardiology, Allegheny General Hospital, Pittsburgh, PA, United StatesWilliam Abraham4Cardiology, Ohio State University, Columbus, OH, United StatesPhilip Adamson5Cardiology, Oklahoma Heart Institute, Oklahoma City, OK, United StatesJay Yadav6Clinical Research, CardioMEMS, Inc., Atlanta, GA, United StatesBrad Jeffries6Clinical Research, CardioMEMS, Inc., Atlanta, GA, United StatesJordan Bauman6Clinical Research, CardioMEMS, Inc., Atlanta, GA, United StatesGerard Criner7Pulmonary and Critical Care Medicine, Temple University Health System, Philadelphia, PA, United States
- Impact of a wireless implanted pulmonary artery pressure monitoring system in heart failure patients with comorbid chronic obstructive pulmonary diseaseBy Gerard Criner, Robert Bourge, Raymond Benza, Philip Adamson, William Abraham, Jay Yadav, Brad Jeffries, Pam Cowart, Jordan Bauman and Fernando MartinezGerard Criner1Pulmonary and Critical Care Medicine, Temple University Health System, Philadelphia, PA, United StatesRobert Bourge2Cardiology, University of Alabama at Birmingham, AL, United StatesRaymond Benza3Cardiology, Allegheny General Hospital, Pittsburgh, PA, United StatesPhilip Adamson5Cardiology, Oklahoma Heart Institute, Oklahoma City, OK, United StatesWilliam Abraham4Cardiology, Ohio State University, Columbus, OH, United StatesJay Yadav6Clinical Research, CardioMEMS, Inc., Atlanta, GA, United StatesBrad Jeffries6Clinical Research, CardioMEMS, Inc., Atlanta, GA, United StatesPam Cowart6Clinical Research, CardioMEMS, Inc., Atlanta, GA, United StatesJordan Bauman6Clinical Research, CardioMEMS, Inc., Atlanta, GA, United StatesFernando Martinez7Internal Medicine, University of Michigan Health System, Ann Arbor, MI, United States
- Allosteric inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) slows airway mucus transport in normal sheepBy William Abraham, Juan Sabater and Tahir AhmedWilliam AbrahamResearch, Mount Sinai Medical Center, Miami Beach, FL United StatesJuan SabaterResearch, Mount Sinai Medical Center, Miami Beach, FL United StatesTahir AhmedResearch, Mount Sinai Medical Center, Miami Beach, FL United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, and a companion volume of self-assessment questions is available. In 2015, the first ERS Practical Handbook, on Noninvasive Ventilation, was added to the series
